Arylmethylamino steroids as antiparasitic agents
In search of antiparasitic agents, we here identify arylmethylamino steroids as potent compounds and characterize more than 60 derivatives. The lead compound 1o is fast acting and highly active against intraerythrocytic stages of chloroquine-sensitive and resistant Plasmodium falciparum parasites (I...
Gespeichert in:
Veröffentlicht in: | Nature communications 2017-02, Vol.8 (1), p.14478-12, Article 14478 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In search of antiparasitic agents, we here identify arylmethylamino steroids as potent compounds and characterize more than 60 derivatives. The lead compound
1o
is fast acting and highly active against intraerythrocytic stages of chloroquine-sensitive and resistant
Plasmodium falciparum
parasites (IC
50
1–5 nM) as well as against gametocytes. In
P. berghei-
infected mice, oral administration of
1o
drastically reduces parasitaemia and cures the animals. Furthermore,
1o
efficiently blocks parasite transmission from mice to mosquitoes. The steroid compounds show low cytotoxicity in mammalian cells and do not induce acute toxicity symptoms in mice. Moreover,
1o
has a remarkable activity against the blood-feeding trematode parasite
Schistosoma mansoni
. The steroid and the hydroxyarylmethylamino moieties are essential for antimalarial activity supporting a chelate-based quinone methide mechanism involving metal or haem bioactivation. This study identifies chemical scaffolds that are rapidly internalized into blood-feeding parasites.
Steroid units can facilitate membrane permeation and bioavailability in drugs. Here, using a medicinal chemistry program, Krieg
et al
. identify an arylmethylamino steroid that kills
Plasmodium
parasites, likely through a chelate-based quinone methide mechanism, and has activity against
Schistosoma mansoni
. |
---|---|
ISSN: | 2041-1723 2041-1723 |
DOI: | 10.1038/ncomms14478 |